LianBio (LIAN) Financials
LIAN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 262.9 million | 26.8 million |
| 2023-06-30 | 278.8 million | 23.3 million |
| 2023-03-31 | 302.6 million | 28.2 million |
| 2022-12-31 | 320.0 million | 26.3 million |
LIAN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -16.0 million | 4.5 million |
| 2023-06-30 | -19.4 million | 4.5 million |
| 2023-03-31 | -17.7 million | 4.3 million |
| 2022-12-31 | -30.9 million | 5.2 million |
LIAN Net Income
No data available :(
LIAN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 252.2 million | - | 2.8 million |
| 2023-06-30 | 267.3 million | - | 3.3 million |
| 2023-03-31 | 286.5 million | - | 3.9 million |
| 2022-12-31 | 302.4 million | - | 4.3 million |
LIAN Shares Outstanding
LIAN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 160000 | 9.0 million | 17.3 million | - |
| 2023-06-30 | 50000 | 9.5 million | 15.6 million | - |
| 2023-03-31 | 19000 | 10.8 million | 15.1 million | - |
| 2022-12-31 | 235000 | 10.6 million | 18.7 million | - |
LIAN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 300018 |
| 2023-06-30 | - | 296781 |
| 2023-03-31 | - | 323366 |
| 2022-12-31 | - | 316476 |
LIAN
Price: $0.32
52 week price:
5-year range yield:
Forward Dividend Yield: 1504.70%
Payout Ratio: -585.37%
Payout Ratio Range:
Dividend Per Share: 4.80 USD
Earnings Per Share: -0.82 USD
P/E Ratio: -4.99
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 104000
Market Capitalization: 34.5 million
Years Paying Dividends: 1